SCHEMBL29633534

SCHEMBL29633534

CCOc1cc(C=O)c(C)c(OCC)c1Br

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.58
POLB P06746 1/20 0.45
ALDH1A1 P00352 11/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
HPGD P15428 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAPT P10636 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
PRKDC P78527 1/20 0.39
HTT P42858 1/20 0.37
GAA P10253 1/20 0.37
KDM4E B2RXH2 3/20 0.37
TSHR P16473 4/20 0.36
HSD17B1 P14061 1/20 0.35
HSD17B10 Q99714 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22946244 1.00 LMNA (0.58) LMNAPOLBALDH1A1CYP1A2CYP2C19
SCHEMBL22946263 0.83 LMNA (0.57) LMNAPOLBALDH1A1CYP1A2CYP2C19
SCHEMBL13664107 0.80 LMNA (0.62) LMNAPOLBALDH1A1CYP1A2CYP2C19
SCHEMBL12957482 0.77 LMNA (0.57) LMNAPOLBALDH1A1CYP1A2CYP2C19
SCHEMBL28700372 0.76 LMNA (0.45) LMNAPOLBALDH1A1CYP1A2CYP2C19
SCHEMBL4879750 0.75 LMNA (0.47) LMNAALDH1A1CYP1A2CYP2C19HPGD
SCHEMBL10969853 0.74 LMNA (0.68) LMNAPOLBALDH1A1HPGDSMN1; SMN2
SCHEMBL22945621 0.73 LMNA (0.67) LMNAPOLBALDH1A1CYP1A2CYP2C19
SCHEMBL38660114 0.73 ALDH1A1 (0.58) LMNAPOLBALDH1A1CYP1A2CYP2C19
SCHEMBL670086 0.73 LMNA (0.77) LMNAPOLBALDH1A1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12338203-B2 Urea compound for antagonizing LPA1 receptor TAISHO PHARMACEUTICAL CO., LTD. (JP) 2025-06-24 US disclosed
CN-119823001-A Urea compounds antagonizing LPA1 receptor 大正制药株式会社 2025-04-15 CN disclosed
CN-114206832-B Urea compounds antagonizing LPA1 receptor 大正制药株式会社 2025-04-04 CN disclosed
CN-114206832-A Urea compounds antagonizing LPA1 receptor 大正制药株式会社 2022-03-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12338203-B2 Urea compound for antagonizing LPA1 receptor LPAR1, LPAR2, LPAR3 LMNA 2200/4885POLB 4112/4885ALDH1A1 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.